The associations between a polygenic score, reproductive and menstrual risk factors and breast cancer risk

被引:0
|
作者
Shaneda Warren Andersen
Amy Trentham-Dietz
Ronald E. Gangnon
John M. Hampton
Jonine D. Figueroa
Halcyon G. Skinner
Corinne D. Engelman
Barbara E. Klein
Linda J. Titus
Polly A. Newcomb
机构
[1] University of Wisconsin Carbone Cancer Center,Department of Population Health Sciences
[2] University of Wisconsin School of Medicine and Public Health,Division of Cancer Epidemiology & Genetics
[3] National Cancer Institute,Department of Ophthalmology and Visual Sciences
[4] University of Wisconsin School of Medicine and Public Health,Norris Cotton Cancer Center
[5] Dartmouth Medical School,Cancer Prevention Program
[6] Fred Hutchinson Cancer Research Center,undefined
来源
Breast Cancer Research and Treatment | 2013年 / 140卷
关键词
Epidemiology; Reproductive and menstrual factors; Breast cancer; Breast cancer susceptibility loci;
D O I
暂无
中图分类号
学科分类号
摘要
We evaluated whether 13 single nucleotide polymorphisms (SNPs) identified in genome-wide association studies interact with one another and with reproductive and menstrual risk factors in association with breast cancer risk. DNA samples and information on parity, breastfeeding, age at menarche, age at first birth, and age at menopause were collected through structured interviews from 1,484 breast cancer cases and 1,307 controls who participated in a population-based case–control study conducted in three US states. A polygenic score was created as the sum of risk allele copies multiplied by the corresponding log odds estimate. Logistic regression was used to test the associations between SNPs, the score, reproductive and menstrual factors, and breast cancer risk. Nonlinearity of the score was assessed by the inclusion of a quadratic term for polygenic score. Interactions between the aforementioned variables were tested by including a cross-product term in models. We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941679 (5p12), rs2981582 (FGFR2), rs3817198 (LSP1), rs3803662 (TOX3), and rs6504950 (STXBP4) with breast cancer. Women in the score’s highest quintile had 2.2-fold increased risk when compared to women in the lowest quintile (95 % confidence interval: 1.67–2.88). The quadratic polygenic score term was not significant in the model (p = 0.85), suggesting that the established breast cancer loci are not associated with increased risk more than the sum of risk alleles. Modifications of menstrual and reproductive risk factors associations with breast cancer risk by polygenic score were not observed. Our results suggest that the interactions between breast cancer susceptibility loci and reproductive factors are not strong contributors to breast cancer risk.
引用
收藏
页码:427 / 434
页数:7
相关论文
共 50 条
  • [31] Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women
    Gary R. Zirpoli
    Ruth M. Pfeiffer
    Kimberly A. Bertrand
    Dezheng Huo
    Kathryn L. Lunetta
    Julie R. Palmer
    Breast Cancer Research, 26
  • [32] Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women
    Zirpoli, Gary R.
    Pfeiffer, Ruth M.
    Bertrand, Kimberly A.
    Huo, Dezheng
    Lunetta, Kathryn L.
    Palmer, Julie R.
    BREAST CANCER RESEARCH, 2024, 26 (01)
  • [33] Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families
    Muranen, Taru A.
    Mavaddat, Nasim
    Khan, Sofia
    Fagerholm, Rainer
    Pelttari, Liisa
    Lee, Andrew
    Aittomaki, Kristiina
    Blomqvist, Carl
    Easton, Douglas F.
    Nevanlinna, Heli
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (03) : 463 - 469
  • [34] Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families
    Taru A. Muranen
    Nasim Mavaddat
    Sofia Khan
    Rainer Fagerholm
    Liisa Pelttari
    Andrew Lee
    Kristiina Aittomäki
    Carl Blomqvist
    Douglas F. Easton
    Heli Nevanlinna
    Breast Cancer Research and Treatment, 2016, 158 : 463 - 469
  • [35] Influence of menstrual and reproductive factors on ovarian cancer risk in women with and without family history of breast or ovarian cancer
    Tavani, A
    Ricci, E
    La Vecchia, C
    Surace, M
    Benzi, G
    Parazzini, F
    Franceschi, S
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2000, 29 (05) : 799 - 802
  • [36] Clinical Impact of Polygenic Risk Score for Breast Cancer Risk Prediction in 382 Individuals with Hereditary Breast and Ovarian Cancer Syndrome
    Stiller, Sarah
    Drukewitz, Stephan
    Lehmann, Kathleen
    Hentschel, Julia
    Strehlow, Vincent
    CANCERS, 2023, 15 (15)
  • [37] A Polygenic Risk Score for Breast Cancer in US Latinas and Latin American Women
    Shieh, Yiwey
    Fejerman, Laura
    Lott, Paul C.
    Marker, Katie
    Sawyer, Sarah D.
    Hu, Donglei
    Huntsman, Scott
    Torres, Javier
    Echeverry, Magdalena
    Bohorquez, Mabel E.
    Martinez-Chequer, Juan Carlos
    Polanco-Echeverry, Guadalupe
    Estrada-Florez, Ana P.
    Haiman, Christopher A.
    John, Esther M.
    Kushi, Lawrence H.
    Torres-Mejia, Gabriela
    Vidaurre, Tatianna
    Weitzel, Jeffrey N.
    Zambrano, Sandro Casavilca
    Carvajal-Carmona, Luis G.
    Ziv, Elad
    Neuhausen, Susan L.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (06): : 590 - 598
  • [38] Polygenic Risk Scores in Breast Cancer
    Mina, Lida A.
    Arun, Banu
    CURRENT BREAST CANCER REPORTS, 2019, 11 (03) : 117 - 122
  • [39] Polygenic Risk Scores in Breast Cancer
    Lida A. Mina
    Banu Arun
    Current Breast Cancer Reports, 2019, 11 : 117 - 122
  • [40] Menstrual and reproductive characteristics and breast cancer risk by hormone receptor status and ethnicity: The Breast Cancer Etiology in Minorities study
    John, Esther M.
    Phipps, Amanda I.
    Hines, Lisa M.
    Koo, Jocelyn
    Ingles, Sue A.
    Baumgartner, Kathy B.
    Slattery, Martha L.
    Wu, Anna H.
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (07) : 1808 - 1822